Cardiovascular magnetic resonance with late gadolinium enhancement improves mortality prediction beyond echocardiography: a comparative effectiveness study by Erik B Schelbert et al.
ORAL PRESENTATION Open Access
Cardiovascular magnetic resonance with late
gadolinium enhancement improves mortality
prediction beyond echocardiography:
a comparative effectiveness study
Erik B Schelbert*, Diego Moguillansky, Timothy C Wong
From 15th Annual SCMR Scientific Sessions
Orlando, FL, USA. 2-5 February 2012
Summary
Adding information from CMR with LGE to ejection
fraction measured by echocardiography significantly
improves the prediction for all cause mortality and bet-
ter classifies individuals at risk.
Background
We tested the hypotheses that 1) ejection fraction (EF)
assessed by cardiovascular magnetic resonance (CMR) is
a stronger predictor of all cause mortality than EF
assessed by echocardiography; and 2) CMR with late
gadolinium enhancement (LGE) improves risk stratifica-
tion over echocardiography EF in Cox regression models
as determined by net reclassification improvement
(NRI). Echocardiography with EF measurement remains
the initial noninvasive imaging modality for evaluation
of patients, and it is used to individualize medical, surgi-
cal, and device-based therapy. Yet, if CMR with LGE
improves risk stratification compared to echocardiogra-
phy, then CMR would demonstrate a potential to opti-
mize care through improved patient selection for
interventions and more efficient allocation of healthcare
resources.
Methods
We prospectively enrolled 1076 consecutive patients
referred for clinical CMR and identified those (n=444)
with contemporaneous (≤ 3 weeks apart) echocardiogra-
phy. Those with confounders such as tako-tsubo cardio-
myopathy or with echocardiography >6 days apart in the
setting of acute myocardial infarction were excluded
(n=7). Baseline characteristics were acquired through
interview and medical record documentation. EF and
LGE were obtained from the final report and correlated
in linear regression models. Vital status was ascertained
from the Social Security Death Index and medical
record review. Cox regression models quantified the
hazards associated with EF decrements, and the NRI
identified whether LGE added prognostic value to cov-
ariates contained in Cox models.
Results
Echocardiography EF and CMR EF were only modestly
correlated (R2=0.66, p<0.001) with minimal bias on
Bland-Altman analysis. There were 30 deaths (6.8%)
over a 2 year follow-up period (median 9 months) CMR
EF was more strongly associated with mortality than
echocardiography EF (c2: 21 vs. 17). LGE was strongly
related to mortality when added to a Cox model with
echo EF (HR 6.15; 95%CI 1.84-20.5) even when adjusted
for age, gender, and diabetes (HR 4.05; 95%CI 1.17-
14.0). LGE improved the net reclassification of patients
at risk for death: NRI=0.75; 95% CI 0.44-1.00 for LGE
added to Cox model with echocardiography EF; and
NRI=0.49; 95%CI 0.08-0.84 for LGE added to Cox
model with echocardiography EF, age, gender, diabetes.
Conclusions
EF measured by CMR provides superior risk stratifica-
tion and better predicts subsequent mortality compared
to EF by echocardiography. CMR with LGE improves
the classification of individuals at risk for death even if
contemporaneous echocardiography derived ejection
fraction is available. These data may have implicationsUniversity of Pittsburgh, Pittsburgh, PA, USA
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for efforts to optimize processes of care, assess compara-
tive effectiveness, and allocate limited health care
resources.
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